Pharmicell Co., Ltd. (KRX:005690)
South Korea · Delayed Price · Currency is KRW 18,290
+90 (0.49%)
At close: Nov 4, 2025
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 1.1 trillion as of November 5, 2025. Its market cap has increased by 245.09% in one year.
Market Cap
1.10T
Enterprise Value
n/a
Revenue
23.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
18,290.00
Market Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 1.10T, an increase of 2,579.38%. That is a compound annual growth rate of 11.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 1.10T | 120.89% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | 1.04T | 103.77% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.68T |
| ALTEOGEN | 27.97T |
| SK Biopharmaceuticals | 9.05T |
| Yuhan | 8.83T |
| HLB Co., Ltd. | 6.38T |
| Peptron | 6.31T |
| PharmaResearch | 5.61T |